Paracrine signalling and MAPK Flashcards

1
Q

What is paracrine signalling?

A

Paracrine signalling involves molecules released by one cell acting on neighbouring target cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the role of Epidermal Growth Factor (EGF)?

A

EGF stimulates cell proliferation and is released from the salivary glands, pancreas, and duodenum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do ion-channel coupled receptors work?

A

Ligand binds to the receptor, causing it to open, allowing ions to flow into the cell. This is common in neurotransmission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are enzyme-coupled receptors? Give an example.

A

Enzyme-coupled receptors are membrane receptors that, when activated, trigger intracellular enzymatic activity. An example is receptor tyrosine kinases (RTKs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the three main types of cell surface receptors?

A

Ion-channel coupled receptors

Enzyme-coupled receptors

G-protein coupled receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do RTKs bind to, and what do they promote?

A

RTKs bind to growth factors (proteins/peptides) that promote cell growth, survival, motility, and proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens when there is overexpression of EGFR (HER1/ErbB1)?

A

Overexpression of EGFR can lead to uncontrolled cell division, contributing to cancers like basal and squamous cell carcinomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the three domains of RTKs?

A

N-terminal domain (extracellular)

Transmembrane domain

Intracellular tyrosine kinase domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does phosphorylation affect proteins?

A

Protein kinases attach a phosphate group (from ATP) to specific amino acids (Ser, Thr, Tyr), activating proteins. Protein phosphatases remove these phosphates to deactivate proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does EGFR activation trigger in the MAPK pathway?

A

EGFR activation leads to receptor dimerization and phosphorylation of tyrosine residues, starting a cascade that activates the MAPK pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the role of RAS in the MAPK pathway?

A

RAS is a small GTPase that, when activated by SOS, exchanges GDP for GTP, triggering a MAPK signalling cascade that affects cell proliferation and survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the key transcription factors activated by ERK in the MAPK pathway?

A

Transcription factors such as c-Myc, Fos, and Jun, which promote cell proliferation, survival, and migration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do protein kinases contribute to cancer?

A

Mutations or overexpression of protein kinases, like EGFR, can lead to continuous signaling and unchecked cell division, contributing to cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What mutations are commonly seen in cancer cells?

A

50% of carcinomas show EGFR overexpression, leading to excessive cell division.

90% of pancreatic cancers have a Ras point mutation that causes prolonged activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What mutation is commonly seen in melanomas?

A

Over 60% of melanomas have a Raf mutation (RafV600E), which is resistant to some drug therapies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the impact of the Ras mutation in pancreatic cancer?

A

A point mutation (G → T, Gly → Val) in Ras leads to prolonged activation because Ras cannot hydrolyze GTP properly, leading to continuous MAPK pathway signalling.

14
Q

What is the significance of mutant Ras in cancer?

A

Mutant Ras is one of the most potent oncogenes, often leading to sustained activation of downstream signaling pathways that drive cancer progression.